NeuroPace Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into NeuroPace (NPCE)

Resumen detallado
NeuroPace raised its 2026 revenue outlook on August 11, 2026, then cut it to $91-$92 million one quarter later. The investigation concerns potential federal securities law…
NeuroPace raised its 2026 revenue outlook on August 11, 2026, then cut it to $91-$92 million one quarter later. The investigation concerns potential federal securities law violations tied to those statements.
NEW YORK, Nov. 16, 2026 /PRNewswire/ -- NeuroPace, Inc. (NASDAQ: NPCE) shares fell over 37% on November 13, 2026, after the Company cut its full-year 2026 revenue guidance to $91-$92 million, one quarter after management raised that same outlook to $99.5-$101.5 million. If you lost money on NeuroPace stock, you are encouraged to submit your loss information now or contact Joseph E. Levi, Esq. at [email protected] or (212) 363-7500.
On the August 11, 2026 second-quarter call, Chief Financial Officer Patrick Williams told investors: "We are increasing full-year total revenue guidance to a range of $99.5 million to $101.5 million, compared to our previous range of $99 million to $101 million." He added: "We expect our third quarter RNS revenue growth to be similar to our first half RNS growth rate of approximately 20% year-over-year." On the same call, Chief Executive Officer Joel Becker cited "continued momentum in the core RNS business and disciplined execution across the organization."
In its third-quarter report, NeuroPace disclosed revenue of $23.1 million. Total revenue declined 1.1% year over year. Management attributed the shortfall to three causes: a sales-force restructuring, disruptions at several large customer accounts, and the continuing effect of exiting the SEEG distribution business. Levi & Korsinsky is investigating whether NeuroPace may not have adequately disclosed these developments and whether potential securities law violations occurred.
Shareholders who lost money on NPCE can request a free review of their NeuroPace losses or call (212) 363-7500.
WHY LEVI & KORSINSKY -- Ranked in ISS Securities Class Action Services' Top 50 Report for seven consecutive years, Levi & Korsinsky, LLP is a nationally recognized leader in shareholder rights…
Q: Who…
Q…
Inicio del artículo, extracto de PR Newswire. Para leer el resto, abra el artículo en el sitio del medio.
MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.prnewswire.com)
